Kelly E. Dooley, MD, PhD, MPH
Year elected: 2019
Current membership category: Active
Johns Hopkins University School of Medicine
600 N. Wolfe Street
Baltimore, MD 21287
United States of America
Kelly Dooley is an Associate Professor of Medicine, Pharmacology, and Molecular Sciences at Johns Hopkins University School of Medicine with appointments in Clinical Pharmacology and Infectious Diseases. Her research focuses on tuberculosis therapeutics with an emphasis on Phase I or II clinical trials of new or existing TB drugs and treatment of HIV/TB co-infection. She has directed several clinical trials involving TB drugs for drug-sensitive TB, drug-resistant TB, TB meningitis, and TB prophylaxis and is involved in the scientific committees of the Tuberculosis Trials Consortium, AIDS Clinical Trials Group, and IMPAACT networks. She serves as a consultant to WHO and has been a member of or technical advisor to the Guidelines Development Committees for treatment for drug-sensitive TB, INH monoresistant TB, and MDR-TB. She has a special interest in optimizing TB drugs for special populations, including children and pregnant women, and for TB meningitis.